COLL250516P35000
- 0.00
- 0.000.00%
Collegium Pharmaceutical Newsroom
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $46
Collegium Pharmaceutical Analyst Ratings
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $36
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $36
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating
Positive Outlook for Collegium Pharmaceutical: Strong Performance and Strategic Growth Initiatives Support Buy Rating
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $46
Collegium Pharmaceutical Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $36
Needham Upgrades Collegium Pharmaceutical(COLL.US) to Buy Rating, Announces Target Price $46
Collegium Pharmaceutical Upgraded to Buy From Hold at Needham
Needham Upgrades Collegium Pharmaceutical to Buy, Announces $46 Price Target
H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $50
Jefferies Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $40
H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $50
Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Collegium Pharmaceutical (COLL)
Needham Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $37
Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)